About Aidence
Aidence was founded in 2015 as a radiology AI company focused on clinical solutions for pulmonary nodule management in routine practice and lung cancer screening. The company developed and deployed AI clinical applications to empower radiologists and other physicians in interpreting medical images. In 2022, Aidence was acquired by RadNet, Inc., a leading provider of diagnostic imaging in the United States, and subsequently integrated into DeepHealth, a wholly owned subsidiary of RadNet. Their flagship product, Veye Lung Nodules (now rebranded as DeepHealth Lung), is an AI-based solution for lung nodule detection, classification, quantification, and growth assessment, which received CE marking in Europe in 2017. As part of DeepHealth, the company continues its mission to push the boundaries of what's possible in healthcare by leveraging advanced AI to enable operational efficiency, clinical confidence, and better delivery of care. DeepHealth now offers a comprehensive portfolio including Enterprise Imaging solutions (Diagnostic Suite, Operations Suite, TechLive) and Population Health solutions covering breast, prostate, chest, neuro, and thyroid imaging. The company serves healthcare institutions worldwide with human-centered, intuitive technology designed to elevate the experience for care teams while improving diagnostic accuracy and workflow efficiency.
Mission & Story
Mission
Empowering breakthroughs in care through imaging
Founding Story
Founded in 2015 in Amsterdam, Aidence was established as a radiology AI company focused on clinical solutions for pulmonary nodule management in routine practice and lung cancer screening.
Clinical Focus
Medical conditions and clinical areas addressed by Aidence.
Who It Serves
Milestones & Awards
Recent Milestones
2022: Acquired by RadNet, Inc.; 2023: Integrated into DeepHealth; Rebranding of Veye Lung Nodules to DeepHealth Lung; Expansion of product portfolio to include comprehensive imaging suites
Key Partnerships
Social & Media
Latest Updates
Company Details
- Founded
- 2015
- Headquarters
- Amsterdam, Netherlands
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
AIQ Global
1-50 employees
AIQ Solutions develops FDA-cleared clinical software that analyzes serial radiographic images to quantify lesion-level changes over time, supporting oncologist decision-making in complex disease management, particularly late-stage cancer care.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.